Terns Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021	2020
Market Capitalization	435	401	383	179	-
Market Cap Growth	-36.79%	4.74%	114.35%	-	-
Enterprise Value	194	138	101	13	-75
PE Ratio	-	-4.45	-6.34	-3.56	-
PS Ratio	-	-	-	178.64	-
PB Ratio	1.84	1.57	1.38	1.11	-
P/FCF Ratio	-5.59	-5.95	-7.75	-4.24	-
P/OCF Ratio	-5.59	-5.95	-7.80	-4.27	-
EV/Sales Ratio	-	-	-	12.66	-
EV/EBITDA Ratio	-2.05	-1.55	-1.71	-0.26	1.92
EV/EBIT Ratio	-2.03	-1.54	-1.68	-0.25	1.90
EV/FCF Ratio	-2.42	-2.05	-2.05	-0.30	2.46
Debt / Equity Ratio	0.00	0.00	0.00	-	-0.11
Debt / EBITDA Ratio	0.00	-0.01	-0.02	-	-0.33
Debt / FCF Ratio	-0.01	-0.01	-0.02	-	-0.42
Quick Ratio	27.26	22.06	33.43	24.34	3.84
Current Ratio	27.85	22.39	33.68	24.48	3.98
Asset Turnover	0	0	0	0.01	0
Return on Equity (ROE)	-35.50%	-33.50%	-32.30%	-28.50%	26.40%
Return on Assets (ROA)	-33.80%	-31.90%	-30.90%	-27.30%	-50.50%
Return on Capital (ROIC)	-43.79%	-40.07%	-22.30%	-31.10%	35.41%
Earnings Yield	-20.95%	-22.49%	-15.76%	-28.08%	-
FCF Yield	-17.46%	-16.82%	-12.90%	-23.60%	-
Buyback Yield / Dilution	-6.62%	-97.76%	-58.69%	-7862.47%	-55.60%
Total Shareholder Return	-6.62%	-97.76%	-58.69%	-7862.47%	-55.60%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).